
Is ocugen stock finally showing signs of weakness?
Apr 07, 2021 · Today, shares of Ocugen (NASDAQ: OCGN) are once again on the move. This time, shareholders in OCGN stock have seen daily double-digit gains as of early morning trading.
Should technical traders consider buying ocugen (ocgn) stock?
Mar 11, 2021 · InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Shares of Ocugen (NASDAQ: OCGN) are on the move once again.Today, OCGN stock is up more than 20% on some pretty bullish news ...
What is the 12-month stock price forecast for ocugen?
Sep 13, 2021 · Shares of OCGN have spiked since markets opened today, rising to as much as $8.75 up from $7.36. The stock closed out the day higher by 15.8%. Prior to the start of the Covid-19 pandemic, Ocugen ...
What is the ocugen-Bharat Biotech partnership?
Jan 04, 2021 · Last month, news that Ocugen would adjourn its annual meeting of shareholders until Jan. 13, 2021 to allow shareholders to have more time to vote on its share increase plan sent OCGN stock higher.

Why is Ocugen stock going up today?
One of the favorite stocks of retail investors in recent years has been Ocugen (NASDAQ:OCGN). This clinical-stage biopharmaceutical company has surged in interest, particularly due to its partnership with Bharat Biotech to develop a Covid-19 vaccine.Mar 17, 2022
Will OCGN stock go back up?
Long-term Ocugen stock forecast 2022-2025 Algorithm-based forecasting service Wallet Investor gave a positive OCGN stock price forecast. The site predicted that the share price could climb over the next year, to $7.2 by March 2023.Mar 23, 2022
Is OCGN good stock to buy?
Is OCUGEN Stock a good buy in 2022, according to Wall Street analysts? The consensus among 3 Wall Street analysts covering (NASDAQ: OCGN) stock is to Hold OCGN stock.
Why Ocugen is down?
Ocugen's OCGN stock declined 3.8% on Tuesday after the FDA placed a clinical hold on a phase II/III immuno-bridging and broadening clinical study on its COVID-19 vaccine, Covaxin.2 days ago
Is Ocugen a buy Zacks?
How good is it? See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.93%2Buy18.44%3Hold9.99%4Sell5.61%2 more rows
What is the target price for OCGN?
Stock Price TargetsHigh$15.00Median$7.00Low$4.00Average$8.25Current Price$2.7900
What does Ocugen Inc do?
Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases.
About OCGN
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases.
Analyst Forecast
According to 4 analysts, the average rating for Ocugen stock is "Buy." The 12-month stock price forecast is 7.90, which is an increase of 6.90% from the latest price.
News
MALVERN, Pa., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc . (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseas...
2 Popular Robinhood Stocks I Wouldn't Buy With Free Money
Robinhood Markets is the company behind investing platform Robinhood. Particularly popular among younger generations, Robinhood has received a lot of praise because of its efforts to "democratize finance." Considering the stock market remains one of the best wealth generators for the common person, that is not a bad thing.
11 Biotech Stocks Popular On Reddit
In this article, we discuss the 11 biotech stocks popular on Reddit. If you want to skip our detailed analysis of these stocks, go directly to the 5 Biotech Stocks Popular On Reddit. Biotechnology is one of the fields in which Reddit investors take active interest amid an explosive growth potential of the biotech industry. According […]
Ocugen Now Relies Solely on a Continued Covid-19 Crisis
I have written two articles about Ocugen (NASDAQ:OCGN) in the past and I must say that if I had to summarize OCGN stock in two words, they would be irrational exuberance. Source: shutterstock.com/PhotobyTawat As of August 9, 2021, the company has a market valuation of $1.61 billion with zero revenue for 2019 and 2018.
Implied Volatility Surging for Ocugen (OCGN) Stock Options
Investors need to pay close attention to Ocugen (OCGN) stock based on the movements in the options market lately.
Ocugen, Inc. (OCGN) Q2 2021 Earnings Call Transcript
With me today is Ocugen's chairman and CEO, Dr. Shankar Musunuri, who will provide a business update, and our financial officer -- chief financial officer and head of corporate development, Sanjay Subramanian, who will provide a financial update.
Why Ocugen Is Rallying Today
Shares of coronavirus vaccine developer Ocugen (NASDAQ: OCGN) are up 6.74% to $8.00 apiece as of 2:30 p.m. EDT. The company provided business updates in its second-quarter earnings release earlier in the day.
Ocugen's (OCGN) Q2 Earnings Miss Estimates, Stock Down
Ocugen (OCGN) miss earnings estimates in the second quarter of 2021. Stock down.
Who is investigating Ocugen?
Pomerantz LLP is investigating claims on behalf of investors of Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ: OCGN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
When is the Ocugen class action lawsuit?
(NASDAQ: OCGN) and certain of its top executives with violations of the Securities Exchange Act of 1934 and seeks to represent purchasers of Ocugen securities between February 2, 2021 and June 10, 2021, inclusive (the "Class Period").
Is there a cost to participate in class action lawsuit in 2021?
NEW YORK, NY / ACCESSWIRE / July 9, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.
